We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current ITRM market cap is 18.35M. The company's latest EPS is USD -2.8560 and P/E is -0.49.
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | -103k | 41k | 50k | 70k | -79k |
| Operating Income | -7.27M | -8.49M | -10.77M | -16.62M | -11.51M |
| Net Income | -4.33M | -9.89M | -12.24M | -3.88M | -12.36M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 233k | 553k | 195k | 503k | 82k |
| Operating Income | -101.83M | -31.57M | -24.34M | -29.12M | -47.39M |
| Net Income | -103.13M | -52.01M | -91.56M | -43.67M | -38.37M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 66.83M | 58.12M | 51.02M | 39.73M | 26.26M |
| Total Liabilities | 38.83M | 39.16M | 43.89M | 36.3M | 32.66M |
| Total Equity | 28M | 18.96M | 7.13M | 3.43M | -6.4M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 25.75M | 32.79M | 91.51M | 66.83M | 26.26M |
| Total Liabilities | 51.99M | 83.35M | 41.28M | 38.83M | 32.66M |
| Total Equity | -26.24M | -50.56M | 50.23M | 28M | -6.4M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -18.47M | -9.59M | -17.22M | -26.49M | -39.33M |
| Investing | 13.96M | 5.11M | 9.45M | 9.81M | 23.34M |
| Financing | -1.82M | 235k | 435k | 445k | 1.03M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -78.89M | -54.53M | -15.84M | -18.47M | -39.33M |
| Investing | 40.1M | -11k | -54.6M | 13.96M | 23.34M |
| Financing | -974k | 64.48M | 83.13M | -1.82M | 1.03M |
| Market Cap | 18.35M |
| Price to Earnings Ratio | -0.49 |
| Price to Sales Ratio | 227.87 |
| Price to Cash Ratio | 3.08 |
| Price to Book Ratio | -2.92 |
| Dividend Yield | - |
| Shares Outstanding | 13.44M |
| Average Volume (1 week) | 93.89k |
| Average Volume (1 Month) | 129k |
| 52 Week Change | 19.78% |
| 52 Week High | 2.64 |
| 52 Week Low | 0.622 |
| Spread (Intraday) | 0.02 (1.45%) |
| Company Name | Iterum Therapeutics PLC |
| Address |
200 s wacker drive chicago, illinois IL 60606 |
| Website | https://www.iterumtx.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
